These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7263242)

  • 21. Ciprofloxacin resistance in Neisseria gonorrhoeae isolated in Mumbai (formerly Bombay), India.
    Divekar A; Gogate A
    Sex Transm Infect; 1999 Apr; 75(2):122. PubMed ID: 10448368
    [No Abstract]   [Full Text] [Related]  

  • 22. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(37):833-7. PubMed ID: 11012233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of several antimicrobial agents against Neisseria gonorrhoeae in the western region of the Kingdom of Saudi Arabia.
    Raddadi AA; Zimmo SK; Abdullah SA
    Sex Transm Infect; 1998 Aug; 74(4):294. PubMed ID: 9924473
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of 250 mg trospectomycin sulfate i.m. vs. 250 mg ceftriaxone i.m. for treatment of uncomplicated gonorrhea.
    Rompalo AM; Colletta L; Caine VA; Linnemeier P; Neumann T; Hook EW; Jones RB
    Sex Transm Dis; 1994; 21(4):213-6. PubMed ID: 7974072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of fluoroquinolone resistant Neisseria gonorrhoeae in New Delhi, India.
    Rattan A; Kumari S; Khanna N; Pandhi RK; Ray K; Bala M; Misra RS
    Sex Transm Infect; 1998 Jun; 74(3):229. PubMed ID: 9849566
    [No Abstract]   [Full Text] [Related]  

  • 26. [A trial in treatment of gonorrhea with a sulphonamide with prolonged effect(sulfapherin)].
    Jorgensen BL
    Ugeskr Laeger; 1971 Jul; 133(26):1257-8. PubMed ID: 5561965
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluoroquinolone-resistant Neisseria gonorrhoeae--San Diego, California, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 May; 47(20):405-8. PubMed ID: 9622458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The return of gonorrhea.
    Dan M
    Isr Med Assoc J; 2004 Mar; 6(3):164-6. PubMed ID: 15055274
    [No Abstract]   [Full Text] [Related]  

  • 29. Update on the management of gonorrhea in adults in the United States.
    Newman LM; Moran JS; Workowski KA
    Clin Infect Dis; 2007 Apr; 44 Suppl 3():S84-101. PubMed ID: 17342672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Increased Neisseria gonorrhoeae quinolone resistance in Amsterdam].
    Peerbooms PG; Spaargaren J; Fennema JS; Cairo I; Coutinho RA
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1899-900. PubMed ID: 11605315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of Neisseria gonorrhoeae strains with decreased susceptibility to ciprofloxacin--Quebec, 1994-1995.
    Ringuette L; Trudeau T; Turcotte P; Yeung K; Rémis R; Perron L; Le Corre I
    Can Commun Dis Rep; 1996 Aug; 22(15):121-4; discussion 124-5. PubMed ID: 8791859
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diagnosis and treatment of gonorrhea in Copenhagen and Frederiksberg].
    Wildt S; Danielsen AG; Friis-Møller A
    Ugeskr Laeger; 2003 Oct; 165(44):4224-7. PubMed ID: 14621556
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibiotic resistance in Neisseria gonorrhoeae.
    Tapsall JW
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S263-8. PubMed ID: 16032562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of pefloxacin in acute gonococcal urethritis.
    Bakare RA; Oni AA; Arowojolu AO; Okesola AO; Ayuba TT; Kehinde AO; Shomuyiwa T
    Afr J Med Med Sci; 1997; 26(3-4):185-6. PubMed ID: 10456167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of acute male gonorrhea by propionyl-erythromycin trisulfazine].
    SISSMANN R
    Cah Rmf Bull Med Guide Pract Rev; 1962 Dec; 76():751-2. PubMed ID: 13977762
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sulfonamide-resistant gonorrhea and method of treatment].
    PORUDOMINSKY IM
    Vestn Venerol Dermatol; 1945; (1):30-4. PubMed ID: 20280558
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sulfonamide therapy].
    Chicoine L
    Union Med Can; 1966 Oct; 95(10):1208-9. PubMed ID: 5920072
    [No Abstract]   [Full Text] [Related]  

  • 38. Cephalothin therapy in male gonorrhea.
    Lucas JB; Thayer JD; Utley PM; Billings TE; Hackney JF
    Antimicrob Agents Chemother (Bethesda); 1965; 5():686-8. PubMed ID: 5884196
    [No Abstract]   [Full Text] [Related]  

  • 39. [Significance of the so-called sulfonamide "renaissance" in dentistry].
    Gabka J
    Zahnarztl Welt Zahnarztl Rundsch ZWR Zahnarztl Reform; 1969 May; 78(10):467-70. PubMed ID: 5253893
    [No Abstract]   [Full Text] [Related]  

  • 40. [The use of sulfamoxole "slow-acting sulfonamide" in stomatology].
    Dechaume M; Laudenbach P; Nguyen-Ngoc-Duc
    Rev Stomatol Chir Maxillofac; 1966; 67(4):233-5. PubMed ID: 5225283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.